Select for export A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/jcp.0000000000001608 PubMed 36193898 Copy citation Copy BibTeX Unknown journal 2022-10-02 Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH Europe PMC Published psilocybin DepressionEnd-of-Life DistressReceptor Pharmacology Randomized Controlled Trial More
Select for export New investigational agents for the treatment of major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/13543784.2022.2113376 PubMed 35975761 Copy citation Copy BibTeX Expert opinion on investigational drugs 2022-09-30 Pochwat B, Krupa AJ, Siwek M, Szewczyk B PubMed Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Review Article More
Select for export Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2022.565 PubMed 36065128 Copy citation Copy BibTeX BJPsych Open 2022-09-05 Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.29167 PubMed 36259015 Copy citation Copy BibTeX Cureus 2022-08-31 Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N PubMed Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17460441.2022.2111415 PubMed 35934973 Copy citation Copy BibTeX Expert Opinion on Drug Discovery 2022-08-21 Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Animal Study More
Select for export A-118 Psychedelic Interventions for Neuropsychological Conditions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/arclin/acac060.118 Copy citation Copy BibTeX Archives of Clinical Neuropsychology 2022-08-16 Brian Peacock OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.06.29.498015 Copy citation Copy BibTeX bioRxiv 2022-07-02 Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionNeuroplasticityMechanism of Action Other More
Select for export Self-administration of Psilocybin in the Setting of Treatment-resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details PubMed 36204170 Copy citation Copy BibTeX PubMed 2022-06-30 Lyons A. Europe PMC Published psilocybin DepressionMicrodosingRandomized Controlled Trial Clinical Trial More
Select for export Neuroimaging in psychedelic drug development: Past, present, and future Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/xwu4j Copy citation Copy BibTeX PsyArXiv 2022-06-29 Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDAddiction Other More
Select for export Neuroimaging in psychedelic drug development: Past, present, and future Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2022-06-29 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDAddiction Other More
Select for export The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2022.40.16_suppl.12097 Copy citation Copy BibTeX Journal of Clinical Oncology 2022-05-31 Manish Agrawal, Paul Thambi, Sarah Shnayder OpenAlex Published psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Postpartum depression: A role for psychedelics? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221093793 PubMed 35638179 Copy citation Copy BibTeX Unknown journal 2022-05-29 Jairaj C, Rucker JJ. Europe PMC Published psilocybin DepressionAgingReview Article Review Article More
Select for export Unraveling the Mysteries of Mental Illness With Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25414 PubMed 35769681 Copy citation Copy BibTeX Unknown journal 2022-05-26 Sotille R, Singh H, Weisman A, Vida T. Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.06.6.30 Copy citation Copy BibTeX Psychiatric News 2022-05-22 Richard Karel OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2022.108195 PubMed 35489438 Copy citation Copy BibTeX Unknown journal 2022-04-26 Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
